SANA FY 2025 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$13M

Operating Income

-$191M

Net Income

-$244M

EPS (Diluted)

$-0.96

Cash Flow

Operating Cash Flow

-$144M

Free Cash Flow

-$145M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$417M

Total Liabilities

$256M

Stockholders' Equity

$161M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$13M	$0	—
Operating Income	-$191M	-$273M	+30.0%
Net Income	-$244M	-$267M	+8.5%